NZ596143A - Delivery devices and their uses with first dose capsules in body accessible to rumen fluid via first outlet and second dose capsule(s) retained over firt outlet - Google Patents
Delivery devices and their uses with first dose capsules in body accessible to rumen fluid via first outlet and second dose capsule(s) retained over firt outletInfo
- Publication number
- NZ596143A NZ596143A NZ59614305A NZ59614305A NZ596143A NZ 596143 A NZ596143 A NZ 596143A NZ 59614305 A NZ59614305 A NZ 59614305A NZ 59614305 A NZ59614305 A NZ 59614305A NZ 596143 A NZ596143 A NZ 596143A
- Authority
- NZ
- New Zealand
- Prior art keywords
- outlet
- dose
- firt
- fluid via
- delivery devices
- Prior art date
Links
- 210000004767 rumen Anatomy 0.000 title abstract 3
- 239000012530 fluid Substances 0.000 title abstract 2
- 239000002775 capsule Substances 0.000 title 2
- 230000000717 retained effect Effects 0.000 title 1
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ59614305A NZ596143A (en) | 2005-09-09 | 2005-09-09 | Delivery devices and their uses with first dose capsules in body accessible to rumen fluid via first outlet and second dose capsule(s) retained over firt outlet |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ59614305A NZ596143A (en) | 2005-09-09 | 2005-09-09 | Delivery devices and their uses with first dose capsules in body accessible to rumen fluid via first outlet and second dose capsule(s) retained over firt outlet |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ596143A true NZ596143A (en) | 2012-08-31 |
Family
ID=46755270
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ59614305A NZ596143A (en) | 2005-09-09 | 2005-09-09 | Delivery devices and their uses with first dose capsules in body accessible to rumen fluid via first outlet and second dose capsule(s) retained over firt outlet |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ596143A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11529310B2 (en) | 2020-12-08 | 2022-12-20 | Ruminant Biotech Corp Limited | Devices and methods for delivery of substances to animals |
-
2005
- 2005-09-09 NZ NZ59614305A patent/NZ596143A/en not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11529310B2 (en) | 2020-12-08 | 2022-12-20 | Ruminant Biotech Corp Limited | Devices and methods for delivery of substances to animals |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2007002526A1 (en) | A MEDICINAL PRODUCT THAT INCLUDES, SEPARATE OR TOGETHER: A) A GLYCOPIRRON SALT; B) A BETA-2 ADRENO-RECEIVER AGONIST SELECTED FROM SALMETEROL AND FORMOTEROL; AND C) A CORTICOSTEROID; PHARMACEUTICAL KIT; AND USE IN THE TREATMENT OF AN INFL DISEASE | |
IL180565A0 (en) | An improved stopcock for administering medicaments into the patient's body | |
CA2807554C (en) | Implantable therapeutic device | |
BRPI0815577A2 (en) | FOXM1 PEPTIDE AND MEDICAL AGENT UNDERSTANDING THE SAME. | |
CL2014001029A1 (en) | Oral solid pharmaceutical dosage form of extended release comprising a matrix formulation comprising an active agent in the form of a tablet or multiparticulate; active agent is an opioid analgesic; and use in the treatment of pain. (div. sun. 499-2012). | |
ATE527976T1 (en) | DEVICE FOR STORAGE, IMMEDIATE PREPARATION AND ADMINISTRATION OF AN ACTIVE SUBSTANCE | |
WO2009158654A3 (en) | Disposable infusion device with cannula port cover | |
CL2007001724A1 (en) | USE OF A STROGEN FOR THE TREATMENT OF DISEASES, CONDITIONS OR SYMPTOMS ASSOCIATED WITH DEFICIENT LEVELS OF STROGENS IN A WOMAN; PHARMACEUTICAL COMPOSITION THAT INCLUDES DAILY DOSAGE UNITS OF ESTRADIOL HEMIDRATE> 0.75 AND 1 | |
WO2009002867A3 (en) | Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement | |
IN2012DN05228A (en) | ||
EP1902663A4 (en) | Apparatus for placing capsule type medical device, apparatus for placing capsule endoscope in the body and capsule type medical device for placement | |
WO2014102613A3 (en) | Device for disposal and neutralization of pharmaceutical agents | |
MX2009000730A (en) | Controlled release formulations and associated methods. | |
UA105210C2 (en) | Anti-cancer vaccine and use thereof | |
EP1698267A4 (en) | Capsule device for medical use | |
IL188732A (en) | Use of ibuprofen and famotidine in the preparation of medicaments | |
AR084713A1 (en) | LAGRIMAL PLUG CONTAINING DRUG FORMULATION | |
IL196394A0 (en) | Implantable sustained drug delivery device for releasing active agents to the osteomeatal complex | |
TW200642682A (en) | A combination of medical drugs to augment the anti-cancer effect of chemotherapy | |
BRPI0816236A2 (en) | Cdh3 peptide and medicinal agent containing the same | |
WO2006133569A8 (en) | Therapeutic polymeric pouch | |
IL195935A0 (en) | 18-methyl-19-nor-androst-4-en 17,17-spiroether (18-methyl-19-nor-20-spirox-4-en-3-one) and pharmaceutical preparations containing the same | |
PL1795186T5 (en) | Flupirtin comprising medicament formulation with a controlled release of the active agent | |
USD579542S1 (en) | Medical liquid administration device | |
IL174691A0 (en) | Infusion preparation containing (2r)-2-propyloctanoic acid as the active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 6 YEARS UNTIL 09 SEP 2015 BY AJ PARK Effective date: 20130326 |
|
ERR | Error or correction |
Free format text: THE FILED DATE HAS BEEN CORRECTED TO 09/09/2004 Effective date: 20130927 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 09 SEP 2016 BY AJ PARK Effective date: 20150824 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 09 SEP 2017 BY AJ PARK Effective date: 20160901 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 09 SEP 2018 BY AJ PARK Effective date: 20170830 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 09 SEP 2019 BY AJ PARK Effective date: 20180827 |
|
ASS | Change of ownership |
Owner name: ARGENTA INNOVATION LIMITED, NZ Effective date: 20181127 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 09 SEP 2020 BY DENTONS NEW ZEALAND LIMITED Effective date: 20190822 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 09 SEP 2021 BY DENTONS PATENT ATTORNEYS AUSTRALASIA LIMITED Effective date: 20200901 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 09 SEP 2022 BY DENTONS PATENT ATTORNEYS AUSTRALASIA LIMITED Effective date: 20210907 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 09 SEP 2023 BY DENTONS PATENT ATTORNEYS AUSTRALASIA LIMITED Effective date: 20220823 |
|
LAPS | Patent lapsed |